Role of renin–angiotensin–aldosterone system inhibitors in heart failure and chronic kidney disease

Renin–angiotensin–aldosterone system (RAAS) inhibitors are the key medications for patients with heart failure and chronic kidney disease. Multiple randomized controlled trials have demonstrated their benefits in an outpatient setting for the treatment of chronic heart failure. Additional advantages...

Descripción completa

Detalles Bibliográficos
Autores principales: Singhania, Namrata, Bansal, Saurabh, Mohandas, Shreya, Nimmatoori, Divya P, Ejaz, Abutaleb A, Singhania, Girish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioExcel Publishing Ltd 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673621/
https://www.ncbi.nlm.nih.gov/pubmed/33240389
http://dx.doi.org/10.7573/dic.2020-7-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673621/
https://www.ncbi.nlm.nih.gov/pubmed/33240389
http://dx.doi.org/10.7573/dic.2020-7-3

Ejemplares similares